Affiliation:
1. Obesity and Diabetes Clinical Research Section, Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona
Abstract
There is growing support for the hypothesis that obesity is an inflammatory condition leading to chronic activation of the innate immune system, which ultimately causes progressive impairment of glucose tolerance. Experimental studies in animals and evidence from prospective and longitudinal studies in humans are consistent with an etiologic role of subclinical inflammation in the pathogenesis of type 2 diabetes, primarily as a mediator of obesity-induced insulin resistance. However, the exact chain of molecular events linking overnutrition, activation of the innate immune system, and impairment of insulin signaling in peripheral tissues remains incompletely understood. Notwithstanding this limitation, treating the underlying subclinical inflammation may constitute a novel approach to prevention and/or treatment of type 2 diabetes.
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference113 articles.
1. Neel JV: Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress?” Am J Hum Genet 14:353–362,1962
2. Ebstein W: Zur therapie des diabetes mellitus, insbesondere über die Anwendung des salicylsauren natron bei demselben. Berlin KlinWochenschrift 13:337–340,1876
3. Stern MP: Diabetes and cardiovascular disease: the “common soil” hypothesis. Diabetes 44:369–374,1995
4. Pickup JC, Crook MA: Is type II diabetes mellitus a disease of the innate immune system?Diabetologia 41:1241–1248,1998
5. Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR: Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 166:387–394,2003
Cited by
183 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献